HGH 191AA (Somatropin)

HGH 191AA (Somatropin) is a recombinant polypeptide identical in primary sequence to endogenous human growth hormone, comprising the complete 191-amino-acid chain. It is produced through recombinant DNA methods and serves as the reference form of growth hormone in laboratory investigations. Researchers employ this molecule to examine native GH structure-function relationships and to benchmark fragments, secretagogues, and analogs under controlled experimental conditions. The compound is supplied exclusively for in-vitro and laboratory research use.

In cell-based and animal research models, HGH 191AA binds the growth hormone receptor (GHR), promoting receptor dimerization and activation of the JAK2-STAT5 signaling cascade. Downstream events include transcriptional induction of insulin-like growth factor-1 (IGF-1) and modulation of genes involved in protein synthesis, lipid mobilization, and carbohydrate handling. Parallel pathways such as MAPK and PI3K-Akt are also engaged in experimental systems, allowing detailed mapping of GH-dependent intracellular responses. These mechanisms are studied strictly within non-clinical laboratory frameworks.

Investigators use HGH 191AA to probe GH-receptor signaling fidelity, IGF-1 induction kinetics, and metabolic pathway regulation in cultured cells and animal models. Key research themes include effects on protein synthesis rates, lipolytic enzyme activity, and glucose metabolism under defined experimental conditions. The molecule also functions as a positive control when comparing the activity of GH fragments, secretagogues, or engineered analogs. All work remains confined to in-vitro assays and laboratory animal research systems.

Laboratory studies consistently demonstrate that full-length HGH 191AA activates GHR-mediated JAK-STAT signaling and elevates IGF-1 expression in responsive cell lines and animal models. Experimental data further document stimulation of protein synthesis machinery and mobilization of stored lipids under controlled research conditions. Comparative work positions the 191-amino-acid sequence as the reference standard against which truncated or modified GH constructs are evaluated. These observations derive from peer-reviewed mechanistic and model-system investigations.

HGH 191AA is typically supplied as a lyophilized powder requiring reconstitution in suitable laboratory diluents for in-vitro or animal-model experiments. Stability is maintained by storage at recommended low temperatures and protection from repeated freeze-thaw cycles. Researchers must adhere to institutional biosafety protocols and confirm that all applications remain limited to non-clinical laboratory investigation. The material is designated strictly for research use and is not intended for any other purpose.